But there's one company on the list of the largest publicly traded stocks that is arguably a screaming deal. This particular company just saw its valuation dip to less than $1 trillion. Patient ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

Artificial intelligence (AI) is driving the highest gains in the market, and several of the largest companies in the world ...

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat. J&J holds a leadership role in diverse healthcare ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...

Today's pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for ...

Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...

UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Several Big Pharma companies unveiled price increases for some 250 drugs during ... Most of the drug price increases are lower than 10%, with the median price increase reaching 4.5%. That’s about the ...

Elon Musk, recognized as both the richest man in the world and the richest person in the world, is the CEO of several high-profile companies ... of the world’s top 10 richest people by September ...